IP Library › Granted Patent US 11,311,641
Granted Patent B1
US 11,311,641 · App. 17/102,257 · Granted Apr 26, 2022

Scaffold wound dressing

Inventor: Mehrdad Mark Mofid (San Diego, CA)
A61L15/32A61L15/40A61L15/58A61L2300/64
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,311,641
App. No.
17/102,257
Granted
Apr 26, 2022
Kind
B1
Abstract

Disclosed is an external wound dressing formed of a bioprotein scaffolding that may include a pressure-sensitive adhesive impregnated in the bioprotein scaffolding. A method of wound treatment can include adhering an external wound dressing formed of a bioprotein scaffolding to an external injury site. Another method can include applying an adhesive to the skin of a patient, placing an external wound dressing formed of a bioprotein scaffolding over an injury site on the skin of the patient, and applying a sealing adhesive on top of the bioprotein scaffolding. Yet another method can include applying an adhesive to the skin of a patient, placing an external wound dressing formed of a bioprotein scaffolding over an injury site on the skin of the patient that has not been stitched, and applying a sealing adhesive on top of the bioprotein scaffolding.

Claims (23)

1. A method comprising:

adhering an external wound dressing formed of an animal-derived bioprotein scaffolding to skin of a patient, over a surgical incision, and to prevent incisional separation, wherein the animal-derived bioprotein scaffolding is formed of bioprotein fibers woven together to form regular or semi-regular boundaries of interstitial spaces.

2. The method of claim 1 , wherein the animal-derived bioprotein scaffolding comprises an insect-derived bioprotein.

3. The method of claim 2 , wherein the animal-derived bioprotein scaffolding comprises a silk bioprotein.

4. The method of claim 3 , wherein the silk bioprotein is obtained from Bombyx mori silkworms.

5. The method of claim 4 , wherein the silk bioprotein has a reduced amount of sericin relative to the amount of sericin naturally present in the silk bioprotein.

6. The method of claim 1 , wherein the adhering comprises application of an adhesive to a patient followed by application of the animal-derived bioprotein scaffolding.

7. The method of claim 1 , wherein an adhesive is integrated with the animal-derived bioprotein scaffolding and the adhering comprises application of the animal-derived bioprotein scaffolding with the integrated adhesive.

8. The method of claim 7 , wherein the adhesive is included within the interstitial spaces.

9. The method of claim 7 , wherein the adhesive is a pressure-sensitive adhesive.

10. The method of claim 1 , further comprising applying a sealing adhesive on top of the animal-derived bioprotein scaffolding.

11. The method of claim 10 , wherein the sealing adhesive comprises cyanoacrylate.

12. The method of claim 1 , wherein the surgical incision has not been stitched.

13. The method of claim 1 , wherein the bioprotein fibers comprise multiple silk protein filaments combined by helical twisting to form a multi-filament bioprotein fiber.

14. The method of claim 1 , wherein the boundaries of the interstitial spaces have an area or dimension that varies by no more than 5%.

15. The method of claim 1 , wherein the boundaries of the interstitial spaces have an area or dimension that varies by no more than 20%.

16. A method comprising:

adhering an external wound dressing formed of an animal-derived bioprotein scaffolding to skin of a patient, over a surgical incision, and to prevent incisional separation, wherein the animal-derived bioprotein scaffolding is formed of bioprotein fibers woven together to form boundaries of interstitial spaces that repeat to form a scaffolding structure.

17. The method of claim 16 , wherein the adhering comprises application of an adhesive to a patient followed by application of the animal-derived bioprotein scaffolding.

18. The method of claim 16 , wherein an adhesive is integrated with the animal-derived bioprotein scaffolding and the adhering comprises application of the animal-derived bioprotein scaffolding with the integrated adhesive.

19. The method of claim 18 , wherein the adhesive is a pressure-sensitive adhesive.

20. The method of claim 16 , further comprising applying a sealing adhesive on top of the animal-derived bioprotein scaffolding.

21. The method of claim 20 , wherein the sealing adhesive comprises cyanoacrylate.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 13, 2024
From: MOFID, M. MARK
To: SYLKE, INC.
Reel/Frame 068271/0862 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 1, 2024
From: MOFID, MEHRDAD MARK
To: MEHRDAD MARK MOFID TRUST DATED APRIL 28, 2015
Reel/Frame 068158/0049 →
Continuity (1)
Continuation In Part 17100675 · Nov 20, 2020
Cited By (1)
US 12,599,694